FY2021 Capital Investment of ¥10.755 Billion and Investment in the Hayashibara Second Plant
First written in FY2021. . Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026Annual update of capital expendituresAnnual report
「During the consolidated fiscal year under review, we made total capital expenditures of ¥26.5 billion, including intangible fixed assets, mainly in the Lifestyle-related segment.」
Capital expenditures in fiscal 2025 were ¥26.517 billion, a substantial increase from ¥16.2 billion in the previous fiscal year. The figure includes investments in electronics and energy, lifestyle-related, and company-wide projects such as rebuilding the head office. - FY2025Annual update of capital expendituresAnnual report
「During the consolidated fiscal year under review, we made total capital expenditures of ¥16.2 billion, including intangible fixed assets, mainly in the Lifestyle-related segment.」
Capital expenditures in FY2025 were ¥16.209 billion, down from ¥17.1 billion in the previous fiscal year. Investments included ¥2.811 billion in electronics and energy and ¥3.987 billion in lifestyle-related. - FY2023Annual update of capital expendituresAnnual report
「During the consolidated fiscal year, the company made total capital expenditures of ¥17.1 billion, primarily in the lifestyle-related segment, including intangible assets.」
Capital expenditures in FY2023 were ¥17.174 billion, up from ¥10.7 billion in the previous fiscal year, mainly in lifestyle-related. - FY2022Annual update of capital expendituresAnnual report
「During the consolidated fiscal year, the company made total capital expenditures of ¥10.7 billion, primarily in the lifestyle-related segment, including intangible assets.」
Capital expenditures in FY2022 were ¥10.725 billion, including ¥2.435 billion in lifestyle-related and ¥3.816 billion in other and corporate-wide investments. - FY2021First statedAnnual report
「The company made total capital expenditures of ¥10.75 billion, primarily for the ¥2.71 billion investment in the new pullulan and enzyme building at Hayashibara Co., Ltd.’s Okayama Second Plant in the lifestyle-related segment.」
In FY2021, the company made capital expenditures of ¥10.755 billion, including ¥2.71 billion invested in Hayashibara’s new pullulan and enzyme building at the Okayama Second Plant.